Dermatitis Market Report 2024: Strategies And Recent Developments | LEO Pharma AS, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A., Bayer AG, Encore Dermatology Inc., Meda Pharmaceuticals Inc., Allergan Plc, Bristol-Myers Squibb Co.,

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Dermatitis Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The dermatitis market size has grown strongly in recent years. It will grow from $6.43 billion in 2023 to $6.79 billion in 2024 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to increased prevalence, diagnostic advancements, treatment options, regulatory approvals.

The dermatitis market size is expected to see strong growth in the next few years. It will grow to $8.37 billion in 2028 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to growing patient awareness, environmental factors. Major trends in the forecast period include research and development, telemedicine and digital health, biologics and targeted therapies, personalized medicine.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=2413&type=smp

Market Segmentation:
The main classes of drugs in dermatitis are corticosteroids, emollients/moisturizers, antihistamines, calcineurin inhibitors, antibiotics, immunomodulators, and interleukin inhibitors. Corticosteroids are a group of steroid hormones generated by vertebrates' adrenal cortex and are also synthetic equivalents of these hormones. The different routes of administration include topical, oral, and injectable and are used in cancer, blood disorders, chronic diseases, and infectious diseases. It is distributed through various channels such as hospitals, retail pharmacies, drug stores, and online or mail pharmacies.

Major Driver - Dermatitis Market Growth Fueled By Increasing Disease Prevalence And Food Allergies
Growth in the dermatitis market is primarily driven by the increasing global prevalence of the disease. The prevalence of dermatitis in children is estimated to be around 15-20% while it is 1-3% in adults. The rising cases of food allergies are adding to the prevalence of dermatitis which ultimately leads to the increase in demand for medicines to cure this disease. For instance, in October 2022, according to the Global Atopic Dermatitis Atlas (GADA), a report published by the International Eczema Council (IEC), a US-based international dermatology association, approximately 223 million individuals were reported to be affected by atopic dermatitis in 2022. Out of this total, around 43 million were in the age group of 1 to 4 years.

Competitive Landscape:
Major companies operating in the dermatitis market include LEO Pharma AS, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A., Bayer AG, Encore Dermatology Inc., Meda Pharmaceuticals Inc., Allergan Plc, Bristol-Myers Squibb Co., Anacor Pharmaceutical Inc., Astellas Pharma Inc., Mylan N.V., Valeant Pharmaceutical Inc., Galderma SA, Dow Inc., Connetics Corporation, Fujisawa Pharmaceutical Company Ltd., AbbVie Inc., F. Hoffmann-La Roche Ltd., Valeant Pharmaceuticals International Inc,, GlaxoSmithKline plc, Medimmune Inc., Bausch Health Co. Inc., Nestlé Skin Health India Pvt. Ltd., Aqua Pharmaceuticals Pvt. Ltd., C.H. Boehringer Sohn AG & Co. KG, Biofrontera AG, Zydus Lifesciences Limited

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

Top Trend - Expanding Dermatitis Market Through Strategic Mergers And Acquisitions
The dermatitis market has witnessed a trend of increasing mergers and acquisitions (M&As), done with the purpose of business expansion and increasing visibility. M&As are playing a significant role in today's world and are assumed to expand this market in the years to come. The vendors in this industry are focusing on collaboration and partnerships to expand their portfolios and improve their market presence. Companies are also strategically making M&As to reduce competition and increase the scalability of their businesses. For instance, in March 2022, Pfizer Inc., a US-based pharmaceutical manufacturing company, acquired Arena Pharmaceuticals, Inc. for an undisclosed amount. With this acquisition, Pfizer aims to strengthen its portfolio of therapeutic candidates in various stages of development within the fields of gastroenterology, dermatology, and cardiology. Arena Pharmaceuticals, Inc. is a US-based clinical-stage company developing treatments for dermatology diseases such as atopic dermatitis (AD).

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Dermatitis Market Characteristics
3. Dermatitis Market Trends And Strategies
4. Dermatitis Market - Macro Economic Scenario
5. Dermatitis Market Size And Growth
…..
27. Dermatitis Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.